- Home
- AIG vs BDX Comparison
AIG vs BDX Comparison
Compare AIG & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIG
- BDX
- Stock Information
- Founded
- AIG 1919
- BDX 1897
- Country
- AIG United States
- BDX United States
- Employees
- AIG N/A
- BDX N/A
- Industry
- AIG Life Insurance
- BDX Medical/Dental Instruments
- Sector
- AIG Finance
- BDX Health Care
- Exchange
- AIG Nasdaq
- BDX Nasdaq
- Market Cap
- AIG 43.9B
- BDX 49.0B
- IPO Year
- AIG N/A
- BDX 1962
- Fundamental
- Price
- AIG $78.60
- BDX $193.00
- Analyst Decision
- AIG Buy
- BDX Buy
- Analyst Count
- AIG 12
- BDX 9
- Target Price
- AIG $89.55
- BDX $210.50
- AVG Volume (30 Days)
- AIG 3.8M
- BDX 2.7M
- Earning Date
- AIG 11-04-2025
- BDX 11-06-2025
- Dividend Yield
- AIG 2.30%
- BDX 2.15%
- EPS Growth
- AIG N/A
- BDX N/A
- EPS
- AIG 5.51
- BDX 5.82
- Revenue
- AIG $27,120,000,000.00
- BDX $21,840,000,000.00
- Revenue This Year
- AIG $2.94
- BDX $5.42
- Revenue Next Year
- AIG $2.27
- BDX $4.40
- P/E Ratio
- AIG $14.21
- BDX $33.17
- Revenue Growth
- AIG 2.52
- BDX 8.24
- 52 Week Low
- AIG $69.24
- BDX $162.29
- 52 Week High
- AIG $88.07
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- AIG 49.98
- BDX 62.84
- Support Level
- AIG $75.46
- BDX $162.46
- Resistance Level
- AIG $77.49
- BDX $180.19
- Average True Range (ATR)
- AIG 1.87
- BDX 4.85
- MACD
- AIG -0.04
- BDX 1.49
- Stochastic Oscillator
- AIG 45.35
- BDX 90.79
About AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.